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ABSTRACT
Trans-splicing of trypanosomatid polycistronic tran-
scripts produces polyadenylated monocistronic mR-
NAs modified to form the 5′ cap4 structure
(m7Gpppm36,6,2′Apm2′Apm2′Cpm23,2′U). NMR and X-
ray crystallography reveal that Leishmania has a
unique type of N-terminally-extended cap-binding
protein (eIF4E4) that binds via a PAM2 motif to
PABP1. This relies on the interactions of a combi-
nation of polar and charged amino acid side-chains
together with multiple hydrophobic interactions, and
underpins a novel architecture in the Leishmania
cap4-binding translation factor complex. Measure-
ments using microscale thermophoresis, fluores-
cence anisotropy and surface plasmon resonance
characterize the key interactions driving assembly
of the Leishmania translation initiation complex. We
demonstrate that this complex can accommodate
Leishmania eIF4G3 which, unlike the standard eu-
karyotic initiation complex paradigm, binds tightly to
eIF4E4, but not to PABP1. Thus, in Leishmania, the
chain of interactions 5′cap4-eIF4E4–PABP1-poly(A)
bridges the mRNA 5′ and 3′ ends. Exceptionally,
therefore, by binding tightly to two protein ligands
and to the mRNA 5′ cap4 structure, the trypanoso-
matid N-terminally extended form of eIF4E acts as the
core molecular scaffold for the mRNA-cap-binding
complex. Finally, the eIF4E4 N-terminal extension is
an intrinsically disordered region that transitions to
a partly folded form upon binding to PABP1, whereby
this interaction is not modulated by poly(A) binding
to PABP1.
INTRODUCTION
The eukaryotic translation machinery is highly complex,
comprising not only ribosomes and tRNAs but also a host
of translation factors that promote mRNA recruitment and
AUG (start codon) recognition, as well as polypeptide elon-
gation and termination (1,2). While it has been evident for
some time that there are variations in terms of the struc-
tural and functional properties of eukaryotic translation
factors across the animals, plants and fungi (3), recent work
has highlighted particularly distinctive features of the try-
panosomatid translation machinery. These differences are
of special interest, not only in the context of our fundamen-
tal understanding of biology, but also because trypanoso-
matids are a worldwide threat to human health and analysis
of distinctive molecular features may help identify potential
drug targets. Approximately 37 million people are thought
to be infected collectively withTrypanosoma brucei (African
sleeping sickness), Trypanosoma cruzi (Chagas disease) and
Leishmania species (responsible for multiple forms of leish-
maniasis), andmanymore people are at risk of infection (4).
It is striking that trypanosomatids manifest a combination
of special cellular and biomolecular attributes; for example,
transcription of large polycistronic chromosomal clusters
followed by trans-splicing and polyadenylation into mono-
cistronic mRNAs (5,6), a pronounced reliance on posttran-
scriptional control mechanisms (7), and other unusual fea-
tures (8–10).
One remarkable feature of trypanosomatid translation
machineries is the involvement of an exceptionally large
number of isomers of both of the translation factors
eIF4E [six isomers (11)] and eIF4G [five isomers (7)]. The
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eIF4E isomers bind to the highly modified cap4 structure
(m7Gpppm36,6,2
′
Apm2
′
Apm2
′
Cpm23,2
′
U) that is added to
the 5′end of the monocistronic mRNAs during processing
(12–14), and are thought to fulfill differentiated functions
over the Leishmania life cycle (15). Another distinctive fea-
ture is that two of the eIF4E isomers (3 and 4) are cyto-
plasmic proteins with long N-terminal extensions that are
not evident in the shared architecture of the eIF4E coun-
terparts that have been characterised in animals, plants and
fungi (11). It is thought that eIF4E3 and eIF4E4 are the
only trypanosomatid eIF4E species likely to underpin gen-
eral translation and that, of these two isomers, eIF4E4 plays
the more significant role (7). Moreover, the N-terminal ex-
tension of Leishmania eIF4E4 can interact directly with
PABP1. PABP1 binding was originally reported to require
the first 86 amino acids of an expression construct that had a
140-codon 5′-deletion from the eIF4E4 reading frame (16),
while later work indicated that PABP1 binding depends on
more central regions of what came to be recognized as the
full-length reading frame (11).
Interactions between proteins that associate with the 5′
end and the 3′ end of mRNA have been identified in ani-
mals, plants and fungi. Up until now, research in this area
has focused on the role of eIF4G as a bridge between the
cap-binding protein eIF4E and the poly(A) binding protein
PABP (17). This is thought to be related to the observa-
tion that mRNAs that are both capped and polyadenylated
are translated more efficiently than those that are merely
capped or polyadenylated (18), although how the simul-
taneous association of eIF4E and PABP with eIF4G pro-
motes synergistic activation of translation initiation by the
5′ and 3′ ends has not been elucidated in mechanistic terms.
A number of reports have however provided useful insight:
for example, the binding of wheat PABP to eIF-iso4F en-
hances eIF-iso4F-cap interactions (19), the binding of yeast
Pab1 toRNA increases this protein’s affinity for eIF4G (20),
while in the same organism the association of eIF4G and of
Pab1 with eIF4E stabilizes eIF4E-cap complexation (21–
24). Human PABP is thought to stimulate translation ini-
tiation by multiple mechanisms, one of which involves en-
hancement of eIF4G binding to the mRNA (25). Overall,
these results convey a picture of mutual enhancement of
many of the interactions in the molecular chain mRNA5′-
m7G-eIF4E-eIF4G-PABP-poly(A)-3′mRNA.At least inas-
much as eIF4E can influence the accessibility of the 5′cap to
proteins involved in the catalysis or modulation of decap-
ping, the relationship between the 5′ and 3′ ends of mRNA
potentially also plays a role in the control of mRNA degra-
dation (26,27).
Taking as our starting point earlier evidence that N-
terminally extended versions of eIF4E (i.e. isomers 3 and
4) can interact with PABP (isomers 2 and 1, respectively;
11,16), this study set out to determine whether an alterna-
tive protein-mediated 5′–3′ mRNA interaction chain forms
in Leishmania, and to characterize key structural features
underpinning its assembly. Techniques of NMR, X-ray
crystallography, fluorescence anisotropy, microscale ther-
mophoresis and surface plasmon resonance have been used
to develop a quantitative understanding of the structures
and interactions underpinning this unique type of interac-
tion chain. In particular, we demonstrate the uniquely piv-
otal structural role of the trypanosomal eIF4E4–PABP1 in-
teraction mediated by the eIF4E4 N-terminal region cen-
tered on the PABP-interacting motif 2 (PAM2).
MATERIALS AND METHODS
Protein purification
All proteins (and protein complexes) were encoded by syn-
thetic reading frames in the E. coli strain NiCo21(DE3;
NEB), grown in Terrific Broth medium supplemented with
25 M ampicillin. Once the culture had reached OD600 =
0.6, expression was induced by the addition of 0.5 mM
IPTG and then each expression strain was incubated with
shaking for 17–22 h at 16◦C. The cells were pelleted by cen-
trifugation at 10 000 rpm for 45 min at 4◦C in a Beckman-
Coulter Avanti J-26 XP centrifuge using a JLA 8.1 rotor,
then re-suspended in lysis buffer [40 mM HEPES pH 7.4,
10% glycerol, 0.5 M NaCl, 2 mM DTT, 0.1% Triton X-
100, 20 mM imidazole, 1 mM PMSF plus other protease
inhibitors (1 tablet of cOmplete™Mini EDTA-free Protease
Inhibitor Cocktail, Roche, per 25 ml of buffer)], using 2 ml
of buffer for each gram of cells. The cells were lysed by son-
ication (4 × 45 seconds on 70% power interspersed with
1min periods on ice). After clarification by centrifugation
at 16 000 rpm for 45 min at 4◦C in a Beckman–Coulter
Allegra 64R centrifuge using F0685 rotor, the supernatant
containing soluble proteins was incubated overnight at 4◦C
with 2 ml of the affinity resin (Amintra Cobalt IDA Resin,
Expedeon for His12-tagged proteins) that had been equili-
brated with the lysis buffer. All affinity purifications were
performed in batch mode. After incubation with lysate, the
resin was first washed 3 × 20 minutes with 12 ml of lysis
buffer (without Triton X-100 and protease inhibitors), and
then 3 × 20 min with 12 ml of wash buffer (the same as ly-
sis buffer but without Triton X100, protease inhibitors and
with lower salt concentration, i.e. 150 mMNaCl). The pro-
teins were eluted from the resin using elution buffer (wash
buffer containing 0.5 M imidazole and 0.1% DDM). De-
pending on the protein yield, between 4 and 10 elutionswere
made, each using 2ml of elution buffer incubated for 15min
with the resin. Gel filtration was used to separate protein
complexes from single proteins and aggregates. Selected elu-
tion fractions derived from affinity purification were pooled
and concentrated to 0.5ml, using Sartorius Vivaspin 3000
MWCO PES 20 ml concentrators (3000rpm in an Eppen-
dorf 5810R centrifuge). For the highly-produced proteins,
and for proteins prone to aggregation, 0.5ml volumes of
the best elution fraction(s) were collected for further use.
These were loaded onto a Superdex®200 Increase 10/300
GL column [GE, separation range 10–600 kDa; flow rate
0.4 ml/min of running buffer (20 mM HEPES, 150 mM
NaCl, 2 mMDTT, 5% glycerol)], using a GE AKTA FPLC
Purifier UPC100, and 0.6 ml fractions were collected. Frac-
tions were analysed via SDS-PAGE and those containing
the purest proteins were selected for further studies. The
protein concentrations in the isolated fractions were deter-
mined by running at least four different dilutions of the pro-
teins on a stained (InstantBlue™ Coomassie Protein Stain,
Expedeon) SDS gel against BSA standards, followed by
densitometric analysis using ImageQuant software (GE).
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The identities of all proteins and protein domains were con-
firmed using mass spectrometry.
Mass spectrometry
The identification of proteins was performed via mass
spectrometry using nanoLC-ESI–MS/MS. The appropri-
ate protein bands were excised from SDS-PAGE gels and
digested with trypsin. The resulting peptides were sepa-
rated by reversed phase chromatography using an Acclaim
PepMap -pre-column cartridge 300 m i.d. × 5 mm 5
m 100 A˚ and an Acclaim PepMap RSLC 75 m × 25
cm 2 m 100 A˚ (Thermo Scientific), installed on an Ulti-
mate 3000 RSLCnano system (Dionex). Twomobile phases
were used: mobile phase A comprised 0.1% formic acid in
water; mobile phase B comprised 0.1% formic acid in ace-
tonitrile. In the next step, the samples were loaded onto the
-pre-column equilibrated in 2% aqueous acetonitrile con-
taining 0.1% trifluoroacetic acid for 8min at 10l min−1 af-
ter which peptides were eluted onto the analytical column
at 300 nl min−1 by increasing the mobile phase B concen-
tration from 4% B to 25% over 22 min then to 90% B over
3 min, followed by a 10min re-equilibration at 4% B. The
eluted peptides were then subjected to electrospray ioniza-
tion and analyzed on a ThermoOrbitrap Fusion system (Q-
OT-qIT, Thermo Scientific). Precursor peptides scanning
from 375 to 1500m/z were analyzed at 120 K resolution (at
200 m/z) with a 2 × 105 ion count target. Tandem MS was
performed by isolation at 1.2Th using quadrupole HCD
fragmentation with a normalized collision energy of 30 and
rapid scan MS analysis in the ion trap. The MS2 ion count
target was set to 3 × 103 and the maximum injection time
was 200 ms. Precursors with charge state 2–6 were selected
and sampled forMS2. The dynamic exclusion duration was
set to 30 s with a 10 ppm tolerance around the selected pre-
cursor and its isotopes. Mono-isotopic precursor selection
was turned on. The instrument was run in top speed mode
with a 1 s cycle. RawMSdata were processed usingMSCon-
vert in the ProteoWizard Toolkit (version 3.0.5759). The
MS2 spectra were searched using the Mascot engine (Ma-
trix Science, version 2.4.1) against the available Leishmania
database and the common Repository of Adventitious Pro-
teins Database (http://www.thegpm.org/cRAP/index.html).
Peptides were generated from tryptic digestion with up to
twomissed cleavages, carbamidomethylation of cysteines as
fixed modifications, and oxidation of methionines as vari-
able modifications. Precursor mass tolerance was 10 ppm
and product ions were searched at 0.8 Da tolerances. Scaf-
fold (version Scaffold 4.3.2, Proteome Software Inc.) was
used to validate MS/MS-based peptide and protein identi-
fications. Peptide identifications were accepted if they could
be established at >95% probability by the Scaffold algo-
rithm and contained at least two identified peptides. Pro-
tein probabilities were assigned by the Protein Prophet algo-
rithm (NESVIZHSKII, 2003). Proteins sharing significant
peptide evidence were grouped into clusters.
Peptide synthesis
Two of the peptides (Supplementary Figure S1A,B) were
synthesized on a CEM Liberty Blue peptide synthesizer
with microwave assistance using default coupling cycles.
The synthesis was performed on a 0.1mmol scale usingRink
Amide MBHA resin (0.33 mmol/g), DMF as a solvent,
20% piperidine in DMF for the deprotection and DIC and
OXYMA pure for couplings. Peptides were N-terminally
acetylated or fluorescently labelled with fluorescein car-
boxylic acid (FAM) attached through a 6-aminohexanoic
acid linker. Cleavage from the resin was accomplished us-
ing TFA:H2O:TIS:EDT, 92.5:2.5:2.5:2.5 (5 ml × 3 h) and
peptides were precipitated using cold ether. Pure peptides
were obtained after preparative HPLC purification on a
Jupiter Proteo 90A˚ 21.2 × 250 mm reverse phase column
using a gradient of 20–60% acetonitrile with 0.1% TFA and
lyophilization. High-resolution mass spectrometry (HR-
MS) data were recorded using electrospray ionization in
positive mode (ESI+) with a Bruker MaXis Impact spec-
trometer. Analytical HPLC experiments were performed
using an Agilent 1290 Infinity LC series system equipped
with anAscentis Express Peptide ES-C18 100× 2.1mm col-
umn, 2.7 m particle size on a 5–95% gradient of acetoni-
trile in water (with 0.1% TFA) over 10 min. The 14mer pep-
tides (labelled with fluorescein isothiocyanate; FITC) used
to test the effects of mutations in the PABP1 binding site
on eIF4E4 were synthesized and HPLC-purified (to 98%
purity) by Thermo Fisher Scientific (Supplementary Figure
S1C).
NMR
Isotopically labelled proteins were prepared by grow-
ing the appropriate strains in an Applikon ez- Control
Bioreactor. The minimal medium was supplemented with
D-glucose (U13C6, 99%, Cambridge Isotope Labs) and
ammonium chloride (15N, 99%). Protein samples were
prepared in HEPES buffers (50 mM, pH 7.5) at con-
centrations in the range 50–200 M. Experiments were
performed on cryoprobe-equipped Bruker 600 and 950
MHz spectrometers in 5mm Shigemi tubes using 300 l
of solution in the presence of 5% D2O at a temper-
ature of 300 K. Backbone assignments were accom-
plished via 1H–15N-HSQC and the triple resonance exper-
iments HNCA/HNCOCA, HNCACB/HNCOCACB and
HNCO/HNCACO. TROSY-based variants were used for
experiments involving larger complexes. Data analysis was
performed using the software packages Bruker TopSpin
3.5pl7 and CCPN Analysis V2.4.2.
X-ray crystallography
For crystallization, the protein was concentrated to 20 mg
ml−1. Crystals of PABP1(J) and PABP1(J) complexed with
peptide were grown at 22◦C by vapour diffusion in 96-well
plates (Swiss-Sci) using a Mosquito liquid handling robot
(TTP LabTech) with 100 nl protein mixed with 100 nl well
liquor. Crystals of PABP1(J) were harvested from a drop
with 0.2 M ammonium sulphate, 0.1 M sodium cacody-
late at pH 6.5, 30% PEG8000 (Structure Screen) and those
of the protein in complex with the peptide were grown in
0.2 M ammonium sulphate; 0.1 M MES; 20% PEG 8000
(ProPlex). Both were cryo-cooled by plunging the crystals
directly into liquid nitrogen. Data were collected at Di-
amond Light Source beamlines IO3 (PABP1(J)) and I24
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Figure 1. Screening regions of Leishmania major eIF4E4 and PABP1 for binding. (A) Different parts of the eIF4E4 reading frame were subcloned and
expressed in E. coli. The overall structure of human eIF4E is shown for comparison. (B) Similarly, different sections of Leishmania PABP1 reading frame
were expressed in E. coli, purified and screened for binding to eIF4E4(iv) using microscale thermophoresis (Supplementary Figure S3). The estimated
affinities (Ka values) between eIF4E4(iv) and the respective PABP1 sections are summarized in panel (C).
(PABP1(J) + peptide) and processed at the beamline with
XDS through theXia2 pipeline. Further processingwas car-
ried out in CCP4. The structure of PABP1(J) was solved
by molecular replacement in Phaser using the structure
of an MLLE domain from human PABP1 (PDB acces-
sion 3PTH) as a search model. Refinement was carried
out using the PHENIX package. The model was first re-
built using PHENIX.autobuild and thereafter refined us-
ing a combination of Phenix.refine and manual interven-
tion using Coot. The structure of the complex with pep-
tide was also solved by molecular replacement using the
refined structure of the PABP1(J) domain alone as the
search model. The structure was refined as above. Individ-
ual chains were defined as TLS groups in the refinement of
both structures. Interactions between amino acid residues
in the crystal structure were displayed using EMBL/EBI
software LIGPLOT+ (version 4.5.3; https://www.ebi.ac.uk/
thornton-srv/software/LIGPLOT). Both structures contain
two PABP1(J) domains in the asymmetric unit, which are
covalently linked through a disulphide bridge between cys-
teine 552 of each molecule. Data collection and refinement
statistics are shown in Supplementary Tables S1 and S2. The
Worldwide ProteinData Bank access codes for the structure
depositions are 6H7A [PABP1(J)] and 6H7B [PABP1(J) +
eIF4E4 peptide]. Full references for the methods used are
given in the Supplementary Data section.
Electrostatic surface modelling and hydrophobicity surface
plots
Electrostatic surface modelling was performed using the
PyMOL V2.0.5 – APBS (Adaptive Poisson–Boltzmann
Solver) plugin (28,29). Hydrophobicity surface plots were
generated using PyMOL script Color h, http://us.expasy.
org/tools/pscale/Hphob.Eisenberg.html (30).
MST, SPR, fluorescence anisotropy measurements
Microscale thermophoresis experiments were performed
using eIF4E4(iv) or eIF4G3 labelled with a fluorescent
tag (Monolith Protein Labeling Kit Red-Maleimide),
or the eIF4G3 peptide VEQIRSVRNNYLEPPYPGF-
SLDEVVR labeled with fluorescein-5-isothiocyanate.
The concentration of the fluorescently labelled protein
(eIF4E4(iv)) was held constant, while the concentration of
non-labelled ligand protein was varied. The experiment was
conducted by preparing 16 tubes with various ratios of the
interacting labelled/non-labelled proteins. The solutions
were introduced into capillaries, which were then loaded
into a Nanotemper Monolith NT.115 instrument for
measurement. For the SPR experiments, eIF4E4(iv) was
immobilized via amine coupling to a Biacore CM5 sensor
chip (GE Healthcare Life Sciences) and titrations against
PABP1(J) were performed in a Biacore T200 instrument. In
order to maximise confidence in the calculated dissociation
constant values (based on kON and kOFF values), two types
of model were fitted to the raw data: a homogeneous 1:1
binding model, and a heterogeneous 1:1 two-ligand model.
The heterogeneous model was found to give better fits.
This is not unexpected, since the mode of protein coupling
used tends to result in a population of protein molecules
that are heterogeneously oriented with respect to the SPR
chip surface (see Supplementary Figure S7). Fluorescence
anisotropy measurements were performed using a PTI
QuantaMaster fluorimeter. To calculate the KD, normal-
ized anisotropy was plotted versus the concentration of
added eIF4E4(v)::PABP1(J), and the data were fitted using
the general equation y = a-b*c∧x with the help of the
OriginLab model Asymptotic 1.
RESULTS
Identification of the PABP1–eIF4E4 interaction domains
Our first objective was to characterize the interactive prop-
erties of eIF4E4 and PABP1 from Leishmania and to de-
fine the domains from the respective proteins that medi-
ate these interactions. We approached this by preparing Es-
cherichia coli expression constructs, as described in Figure
1A,B, that cover all potential interaction sites. The full-
length eIF4E4 and PABP1 DNA reading frames were gen-
erated synthetically in codon-optimised form for expression
inE. coli. A polyhistidine affinity tag (His12) was introduced
at the N-terminal or C-terminal end of each protein do-
main used in this study (Supplementary Figure S2), thus
providing tagged derivatives that could be employed in dif-
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ferent combinations with untagged proteins in the various
biophysical procedures used for quantitative characteriza-
tion. By studying the behavior of the respective recombi-
nant protein domains indicated in Figure 1A,B, we discov-
ered that a number of them, especially the larger ones, were
prone to aggregation. Fortunately, by creating a large num-
ber of (overlapping) domain constructs we could identify
a subset of protein domains with suitable solubility char-
acteristics that covered all sections of PABP1 and the ex-
tended N-terminal region of eIF4E4. The selected protein
domains were then analyzed in microscale thermophore-
sis binding assays (Figure 1C; Supplementary Figure S3),
leading to a categorization of the domains into groups that
manifested strong binding and other groups that engaged in
relatively weak binding. The main outcome of these experi-
ments was identification of a strong interaction between the
PABC domain of PABP1 (here prepared as segment J; Fig-
ure 1B) and an approximately 5 kDa region [segment (iv);
Figure 1A] of the extended N-terminal domain of eIF4E4.
Analysis of the sequence of eIF4E4(iv) revealed the pres-
ence of a candidate PAM2 motif, a consensus recognition
site found in other proteins that bind to poly(A)-binding
proteins (31,32). This finding is consistent with the results
of previous (qualitative) pull-down and two-hybrid assay
experiments performed with PABP1 and eIF4E4 (7). An-
other report has attempted to predict molecular interac-
tions between Leishmania PABP1 and eIF4E4 by modeling
MLLE and PAM2 domains from other (human) proteins
(33). In order to obtain definitive experimental information
on the interaction architecture of the Leishmania proteins,
we decided to perform structural analysis on the PABP1 and
eIF4E4 domains identified by our interaction screening pro-
cedure.
Structural analysis of PABP1–eIF4E4 interactions
We prepared uniformly 15N-,13C- labeled PABP1(J) and
eIF4E4(iv) and used these protein domains, together with
the non-labelled versions, for NMR analysis. By this means,
we were able to identify the amino acids comprising the
respective binding motifs (Figure 2). The 1H–15N-HSQC
NMR spectra showed PABP1(J) to be folded (Figure 2A),
while eIF4E4(iv) displayed amide resonance chemical shift
dispersion characteristic of an intrinsically disordered do-
main (Figure 2B). Addition of either unlabeled domain to
the other in uniformly 15N–13C-labelled form induced se-
lective chemical shift perturbations indicative of specific
binding. Binding of unlabeled eIF4E4(iv) to 15N-13C- la-
beled PABP1(J) (Figure 2A) enabled us to identify inter-
actions involving residues in PABP1 that manifest homol-
ogy to the 70-residue MLLE (here MFLE) domain (34). In
the reciprocal experiment, addition of PABP1(J) to 15N–
13C-eIF4E4(iv) caused major chemical shift perturbations
(CSPs) that map to the region N141-G150 of eIF4E4 (Fig-
ure 2B), which matches the putative PAM2 motif that we
identified via our initial binding studies (see above). In an
additional experiment, we assessed the impact of adding
a short (14-amino-acid-long) unlabelled synthetic peptide
centred around the eIF4E4 PAM2 motif to 15N–13C- la-
beled PABP1(J) (Supplementary Figure S4A). The resulting
CSPs in the PABP1(J) 1H–15N-HSQC spectrummapped ex-
actly onto those observed in Figure 2A, thus confirming the
major role of the PAM2 motif in determining the specific
association of eIF4E4 with PABP1.
In further work, we were able to solve the crystal
structures of PABP1(J) (Figure 3A) and of PABP1(J) co-
crystallized with a synthetic eIF4E4 PAM2 peptide (Fig-
ure 3B), both to a resolution of ∼2 A˚ (Supplementary
Tables S1 and S2). Obtaining these structures enabled us
to locate the binding motif for eIF4E4 in relation to the
three-dimensional structure of Leishmania PABP1 (Figure
3B, C, E, G). The structure of the complex reveals how the
eIF4E4 peptide binds across the three -helical segments of
the 70-residue PABC domain of PABP1 in a similar fashion
to other PABC-interacting proteins (34). The peptide (Fig-
ure 3D, F) includes the PAM2 motif (MNPNATEFMP)
of eIF4E4, which follows the same pattern of PAM2 mo-
tifs found in other proteins, including Paip1 and eRF3
[-(P/V)-A––F-P (34)]. The eIF4E4 peptide in the crystal
structure assumes an extended conformation, whereby the
PAM2 motif wraps around the core KITGMFLE motif of
the PABC domain of PABP1 (Figure 3B, C, E, G). Consis-
tent with the structures of other analogous complexes, bind-
ing is associated with relativelyminor changes in the confor-
mation of the PABP1 fragment; the side chains of only Lys
520 and Glu 527 are affected.
The phenylalanine residue in the PAM2motif (here F147,
circled in Figure 3C, E) fits into a large pocket formed
of multiple residues on the PABC domain, including three
of the KITGMFLE motif residues (Supplementary Fig-
ure S5). The proline at position 142 (Figure 3D, F) reori-
ents the path of the eIF4E4 peptide across the three he-
lices, thus influencing the configuration of the multiple in-
teractions that can be identified between the two partner
molecules in the complex (as highlighted in the LIGPLOT
representation in Supplementary Figure S5E). Next to this
proline is an asparagine (N143; Figure 3F, G) whose polar
and aliphatic side chain would not be expected to engage
in significant interactions with the PABP1 protein (Figure
3A, B, G). The phenylalanine (F525) in the PABC core mo-
tif of Leishmania PABP1 (KITGMFLE) represents a varia-
tion on the MLLE motif generally found in other poly(A)-
binding proteins; this residue is located on -helix 3 and
forms part of a hydrophobic pocket that interacts with
M140 in the eIF4E4 sequence (Figure 3C,D; Supplemen-
tary Figure S5A,E). A144 in eIF4E4 fits into the hydropho-
bic pocket formed partially by the PABP1 G523 that also
sits on -helix 3 (Figure 3A, C, D). The carbonyl oxygens
of both P142 and A144 interact with the Nε atom of K520
at the N-terminal end of -helix 3 (Figure 3E, F). It is also
noteworthy that the crystal structure indicates that M148
is angled away from (and does not interact with) P519 (Fig-
ure 3G; Supplementary Figure S5C,E), although our NMR
data (Figure 2B) reveal that the M148 backbone amide un-
dergoes a significant change in its environment upon bind-
ing to PABP1. Overall, the multiple interactions identified
here (most of which are highlighted in the LIGPLOT in
Supplementary Figure S5E) provide a basis for understand-
ing the molecular principles underpinning tight binding be-
tween eIF4E4 and PABP1.
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Figure 2. NMR spectra reveal interacting residues and conformational changes. (A) 1H–15N HSQC spectra of 15N,13C-labelled PABP1(J) in the absence
(blue) and presence (red) of unlabeled eIF4E4(iv), with residues undergoing chemical shift perturbations (CSPs) upon binding highlighted. (B) The equiva-
lent experiments were performed using 15N–13C-eIF4E4(iv) plus unlabelled PABP1(J). The residues affected by binding are also highlighted in the sequence
for PABP1 (blue highlighted amino acids at the top of panel A) and in the sequence for eIF4E4 (blue highlighted residues at the top of panel B).
Figure 3. X-ray crystallographic analysis of the Leishmania PABP1 PABC domain binding to eIF4E4. (A) Crystal structure of PABP1(J), featuring the
-helices and location of the MFLE motif (residues 524–527) in the PABC domain. (B) Electron density of the eIF4E4 PAM2 peptide overlaid over the
PABP1 PABC1 structure. (C) Hydrophobicity surface map of the PABP1 PABC structure together with the bound backbone structure of the eIF4E4
PAM2 peptide. The intensity of the red shading increases with predicted hydrophobicity. (D) Enlarged and fully annotated backbone structure of the
eIF4E4 PAM2 peptide showing predicted hydrophobicity features. (E) Electrostatic potential surface map [highlighting relatively more positively charged
(basic; blue) and relatively more negatively charged (acidic; red) regions] of the PABP1 PABC structure overlaid with the backbone structure of the eIF4E4
PAM2 peptide. (F) Enlarged and fully annotated eIF4E4 peptide backbone structure colour-coded according to electrostatic potential. (G) Image in panel
E rotated to improve view of interactions with the N-terminal half of the eIF4E4 peptide. More details are provided in Supplementary Figure S5.
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Table 1. PAM2-motif FITC-labelled peptides
Mutations Sequence KD (nM)
WT HHMNPNATEFMPGR 33.0 ± 0.9
M140A HHANPNATEFMPGR 34.3 ± 1.3
N143A HHMNPAATEFMPGR 69.2 ± 4.9
E146A HHMNPNATAFMPGR 163.0 ± 16.4
F147A HHMNPNATEAMPGR 127.3 ± 13.4
M148A HHMNPNATEFAPGR 62.8 ± 3.1
5 x A HHANPAATAAAPGR n.d.*
*not detectable
Mutational analysis of the roles of conserved residues in
eIF4E4
The structural data prompted us to use mutational anal-
ysis to explore further the role of conserved residues in
the eIF4E4 PAM2 motif in binding. In order to do this,
we performed microscale thermophoresis experiments us-
ing a set of FITC-labelled synthetic 14mer peptides (Table
1; Supplementary Figure S1C) in binding experiments with
PABP1(J). Considering first the mutations affecting hy-
drophobic residues, we found that single-site alanine substi-
tution of the methionines at positions 140 and 148 hadmin-
imal impacts on binding affinity [compared to the affinity
calculated for the ‘wild-type’ peptide (Table 1)]. TheM140A
result indicates that the side chain of alanine (which, like
that of methionine, is categorized as hydrophobic) can sub-
stitute adequately for that of methionine as a moiety that
can interact with the hydrophobic pocket partly formed by
F525 in PABP1, whereby other compensating interactions
could also potentially be involved. The small effect on bind-
ing affinity of M148A, on the other hand, is consistent with
the observation that this residue is oriented away from the
PABP1 protein surface (Figure 3G; Supplementary Figure
S5C). Moving on to position 147, we see that an alanine
does not achieve as energetically favourable a fit into the hy-
drophobic pocket on PABP1 (Supplementary Figure S5) as
F147, since theF147Amutant peptidemanifests amarkedly
reduced affinity relative to the wild-type sequence (Table 1).
We next looked at the effects of substituting amino acids
with charged or polar side chains. Replacement of the glu-
tamic acid residue at position 146 by alanine also leads to
a strongly reduced affinity value in this assay; this is likely
to be due to the loss of the predicted electrostatic interac-
tion between eIF4E4 E146 and PABP1 K520 (Figure 3E).
In contrast, N143A had no effect on binding (Table 1),
a result that is consistent with the structure-based predic-
tion that N143 does not engage in strong interactions with
PABP1. Finally, the effect on binding of simultaneous mul-
tiple alanine-substitutions of all of the individual PAM2
motif residues described above confirms their necessity for
detectable binding (Table 1; peptide 5 x A), and also empha-
sizes the importance of a combination of different atomic
interactions.
Characterization of a PABP1–eIF4E4–eIF4G3 complex
Given that the eIF4E4 factor carries both the PABP1-
binding (PAM2) site in its N-terminal extension (Figure
1A) and eIF4G3-binding-motifs on its dorsal face, we next
examined whether a longer Leishmania eIF4E4 fragment
(segment v; Figure 4A) could serve as the platform for
formation of both heterodimeric and heterotrimeric com-
plexes as the result of co-expression in vivo. Taking into
account our previous observations of the propensity of
some of the synthetic Leishmania protein domains to ag-
gregate at high concentrations, we used a dual expression
plasmid to support synthesis of PABP1(J) in parallel with
eIF4E4(v) (Supplementary Figure S2). Co-expression was
successful, in that it not only led to incorporation of al-
most all of the synthesized eIF4E4(v) protein into the ex-
pected PABP1(J):eIF4E4(v) complex, but thereby also sup-
pressed much of the aggregation and degradation that was
otherwise observed when eIF4E4(v) was synthesized alone
in E. coli.
Development of an improved procedure to isolate a sta-
ble and soluble heterodimeric complex encouraged us to at-
tempt formation of a heterotrimeric complex that would
throw more light onto the eIF4E4-mediated interactions
that bridge the 5′ and 3′ ends of mRNAs in Leishmania.
Since eIF4E4(v) included the putative binding motifs for
both PABP1 and eIF4G3 (Figure 4A), we tested the hypoth-
esis that eIF4E4(v) would be able to form a scaffold upon
which the two other protein domains could be assembled.
We showed that this heterotrimeric complex could indeed be
formed via two types of experiment. First, we used cobalt-
column affinity chromatography followed by gel filtration
chromatography to identify complexes formed upon mix-
ing eIF4E4(v), PABP1(J) and full-length eIF4G3 (Figure
4B). By this means, we were able to isolate a soluble het-
erotrimeric eIF4E4(v):PABP1(J):eIF4G3 complex that, in
the initial purification step, had been selected on the basis
of its association with eIF4G3-His12 (Figure 4C).
In the second type of experiment, we collected 1H-
15N- HSQC spectra of the heterodimeric complex formed
by 15N-,13C-labelled PABP1(J) and 15N-,13C- labeled
eIF4E4(v), and found that the addition of a synthetic
28mer peptide that includes the eIF4G3 motif (35) that
binds the eIF4E4 dorsal face induced specific NMR CSPs
(Supplementary Figure S4B). Since the PABP1(J) domain
contains only the PAM2-binding PABC site, these data
suggest that eIF4G3 can participate in a heterotrimeric
eIF4E4:PABP1:eIF4G3 complex by virtue of an interaction
with eIF4E4. In combination with fluorescence anisotropy
data described in the next section, this indicates that, like
eIF4E proteins from other organisms, Leishmania eIF4E4
has a dorsal binding domain structure for binding to the N-
terminal region of eIF4G3 that can support heterotrimeric
complex formation (Figure 4; Supplementary Figure S6).
The eIF4E4 residues thought to be directly involved in
eIF4G3 binding differ from those involved in complexa-
tion of the human eIF4G and eIF4E proteins (7). How-
ever, the functional role of these dorsal binding interac-
tions is equivalent to that found in other eIF4E species, and
we therefore did not prioritize further characterization of
these CSPs in the present study. Instead, we next focused
on the question as to whether we could detect any form
of interaction between eIF4G3 and PABP1. Most eukary-
otic eIF4G proteins possess an N-terminal PABP-binding
site that binds to the RRM1–2 domain of PABP (2). Al-
though sequence comparisons reveal that the Leishmania
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1187/5198480 by guest on 22 N
ovem
ber 2018
8 Nucleic Acids Research, 2018
Figure 4. Formation of a PABP1:eIF4E4:eIF4G3 complex. (A) Overview of proteins and protein segments co-synthesized in E. coli, featuring PABP1(J)
and eIF4E4(v) as well as relevant amino acid sequence motifs. (B) Co-migration of eIF4G3-His12, eIF4E4(v) and PABP1(J) proteins on a Sephadex 75 gel
filtration column after elution from a cobalt affinity column. (C) Collection of fractions 7–8 yielded a highly pure preparation of the complex: PABP1(J)-
eIF4E4(v)-eIF4G3. The identities of these proteins were confirmed using mass spectrometry.
eIF4G proteins lack the directly equivalent N-terminal re-
gion (Supplementary Figure S6A) we could not, on this ba-
sis alone, exclude the possibility that a different type of site
with a corresponding role might exist in an alternative do-
main context.
Unique interaction architecture underpinning the trypanoso-
mal 5′–3′ bridging complex
We wanted to establish a quantitative understanding of the
relative significance of interactions between the Leishmania
cap-binding complex factors eIF4E4, eIF4G3 and PABP1
using protein domains or full-length proteins, rather than
peptides. We selected analytical methods that can be ap-
plied at low protein concentrations, thus minimizing the oc-
currence of aggregation-related artefacts: microscale ther-
mophoresis, surface plasmon resonance and fluorescence
anisotropy (Figure 5; Supplementary Table S3). Microscale
thermophoresis was performed using proteins that had been
labelled using Alexa 647. We observed tight binding be-
tween eIF4E4(iv) and PABP1(J) (KD = 0.22× 10−7 M; Fig-
ure 5A). High-affinity binding between eIF4E4(iv) (in this
case immobilized) and PABP1(J) was confirmed by surface
plasmon resonance measurements. In this case, a heteroge-
neous model assuming a combination of two different bind-
ing states of eIF4E4(iv) generated good fits to the data (the
average of the calculated KD values for the two states in
this model (KDav) = 3.3 × 10−7 M; Supplementary Figure
S7, Supplementary Table S3). Given the predicted role of
PABP1 F525 in forming the hydrophobic pocket that the
eIF4E4 M140 side chain fits into, and the fact that it is un-
usual to find a phenylalanine substituted for a leucine in the
MLLE motif, we also tested the importance of F525 in the
interaction with eIF4E4. Mutation of this phenylalanine to
an alanine [PABP1(J) F525A] resulted in a major loss in
binding affinity (KD = 5.5 × 10−7 M; Supplementary Ta-
ble S3) as measured using microscale thermophoresis. The
PABP1(J) F525A KD value is 25 times greater than that of
the corresponding non-mutated PABP1(J) value.
Fluorescence anisotropy experiments revealed that a
high-affinity interaction (average of calculated KD values
= 3.4 × 10−7M) also occurs between Alexa-647-labelled
eIF4G3 and the complex eIF4E4(v):PABP1 (Figure 5C).
The latter binding result was confirmed through microscale
thermophoresis experiments using full-length eIF4G3, al-
though in this case partial fluorescence quenching limited
the accuracy of the KD calculation and this result qualifies
only as supporting evidence (Supplementary Figure S8A).
In contrast, microscale thermophoresis detected no binding
between eIF4G3 and PABP1 (Figure 5D; see also control
in Supplementary Figure S8A), and this negative outcome
was also reflected in pull-down results obtained with lysates
fromE. coli strains that co-produce these two proteins (Sup-
plementary Figure S8B). Finally, microscale thermophore-
sis analysis of the binding between full-length PABP1 and
eIF4E4(iv) revealed no effect of the presence of poly(A) ri-
bonucleotides of length 12 or 20 on the affinity between
these two proteins (data not shown).
DISCUSSION
In this study, we have demonstrated that the N-terminal ex-
tension found in Leishmania eIF4E4 acts as a focal struc-
tural element in formation of a unique type of eukary-
otic cap-binding complex architecture. Indeed, because the
N-terminal extension adds a PABP1 binding site to the
cap- and eIF4G- binding sites that are generally present in
previously described eIF4E species from across the king-
doms, the Leishmania eIF4E4 factor replaces eIF4G as
the core ‘scaffolding’ protein in the cap-binding complex
(Figure 6A). We conclude that this N-terminally extended
eIF4E anchors eIF4G and PABP1 directly to 5′-end-cap4-
modified mRNAs.
While the ‘scaffolding’ function in cap-complex assembly
described here is an exceptional role for an eIF4E protein, it
also serves to underline the wider importance of some form
of molecular bridging between the cap-binding complex
and the poly(A) binding protein in eukaryotic cells. Inmany
other organisms, strong binding between eIF4G and PABP
promotes translation (17,20,23,25). We find that participa-
tion in this core bridging function is not evident in theLeish-
mania eIF4G isomer that binds to eIF4E4. We have used
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Figure 5. Quantitative characterization of interactions ofLeishmania cap-complex proteins.Microscale thermophoresis titrations (A) of Alexa-647-labelled
eIF4E(iv) against non-tagged PABP1(J) domain and surface plasmon resonance (SPR) experiments (B) confirmed tight binding between eIF4E4(iv) and
PABP1(J) (compare Figure 3). In the SPR measurements, eIF4E4(iv) was immobilized on the chip surface and PABP1(J) was passed over the chip at
concentrations of 0.02 (black line), 0.09, 0.19, 0.37, 0.74 and 1.49 (pink line) M (binding phase). At the time-point indicated by the arrow, the protein
solution was replaced by buffer only, thus initiating the release phase. The best fits to the SPR data were obtained using using a heterogeneous binding
model (Supplementary Figure S7; Supplementary Table S3). Fluorescence anisotropy measurements (C) detected binding of Alexa-647-labelled eIF4G3 to
the complex eIF4E4(v):PABP1(J). In contrast, no binding could be detected between Alexa-647-labelled eIF4G3 and PABP1 (D). The respective binding
data are summarized in Supplementary Table S3.
Figure 6. The ‘scaffolding’ component in the trypanosomatid cap-binding
complex is eIF4E4. (A) The structural data and quantitative interac-
tion measurements reported here demonstrate that Leishmania eIF4E4
(E) engages in specific interactions (continuous edges in the interaction
graph) with PABP1 (P) and with eIF4G3 (G), whereas there was no de-
tectable interaction between PABP1 and eIF4G3. The known interactions
between PABP1 and poly(A), and between eIF4E4 and the cap4 (5′C4)
structure, complete the map of the eIF4G3–eIF4E4(cap4)-PABP1-poly(A)
biomolecular chain. (B) In all other known eukaryotic cap-binding com-
plexes, the core scaffolding protein is eIF4G, as reflected in this interaction
map.
two independent quantitative measurement techniques to
resolve uncertainty created by contradictory results from
previous attempts to detect binding between eIF4G3 and
PABP1 that were based on qualitative pull-down experi-
ments and two-hybrid assays (16,36,37). Our conclusion is
that these two proteins do not participate in a readily de-
tectable interaction, and that if there is any (potentially non-
specific) binding between the two, this is at a much lower
affinity than that measured for the pairs eIF4E4–PABP1
and eIF4E4–eIF4G3.
The N-terminally extended versions of eIF4E (isomers
3 and 4) have been described as essential proteins that are
present in at least the promastigote stage of the trypanoso-
matid developmental cycle (7). These two isomers are of
a higher abundance than the other trypanosomatid eIF4E
isomers and are the only two for which there is evidence of
involvement in cap-complexes implicated in general trans-
lation, whereby more recent reports have emphasized the
primacy of eIF4E4 in promoting cap-dependent initiation
(7,37). In this context, it is noteworthy that the Leishmania
eIF4E3 N-terminal region possesses a sequence that is only
partly related to the PAM2 motif found in eIF4E4 (Supple-
mentary Figure S6B). Moreover, there is considerably less
similarity in the PABC domain (outside of the KITGM-
LLE motif) between PABP1 and the PABP isomers 2 and 3
within L.major than there is similarity between the equiva-
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lent region of PABP1 sequences across nine species ofLeish-
mania and Trypanosoma (Supplementary Figure S6C,D).
Overall, these observations suggest that eIF4E4-mediated
mRNA 5′–3′ bridging interactions play a distinct and pos-
sibly dominant role in Leishmania translation initiation.
In addition, these sequence alignment results alert us to
the possibility that a comparable emphasis on the eIF4E4–
PABP1 interactionmay apply in otherLeishmania (andTry-
panosoma) species (Supplementary Figure S6D). We con-
clude that the role of eIF4E3 requires clarification. Like
eIF4E4, it is exclusively present in the cytoplasm of pro-
mastigotes, but its mRNA cap binding affinity is lower than
that of eIF4E4 (7) and, as we have seen, there are significant
differences between the key motifs in the N-terminal exten-
sions of the respective isomers (SupplementaryFigure S6B).
Future work will need to determine whether eIF4E3 partic-
ipates in the assembly of a complex (involving eIF4G4 and
PABP2) of equivalent structural and functional importance
to that of eIF4G3:eIF4E4:PABP1.
From theX-ray andNMRstructural data in this studywe
have learned that there are a large number of atomic inter-
actions underpinning binding between eIF4E4 and PABP1.
By performing microscale thermophoresis binding assays
using FITC-14mer peptides carrying sequence variants, we
have deepened understanding of the relative significance
of the respective amino acids around the PAM2 motif in
eIF4E4. These experiments have demonstrated the signifi-
cant roles of E146 and F147, and the at most minor roles
of N143 and of M148, in binding. In the case of N143,
the NMR data indicated that binding between eIF4E4 and
PABP1 has an effect on the environment of this residue, but
the X-ray results indicate that it does not engage in signif-
icant interactions. In addition, the peptide binding results
(Table 1) demonstrate that a combination of multiple inter-
actions, including the partitioning of multiple (hydropho-
bic) amino acid side chains into non-aqueous regions (pock-
ets) shared by the two proteins (Supplementary Figure S5),
underpins binding. This combination of polar, electrostatic
and hydrophobic interactions shows some similarity to the
molecular basis of binding observed in the protein pairs
PABPC1-Paip2 and EDD-Paip1 (34), particularly in terms
of engagement of the PAM2motif (eIF4E4) with hydropho-
bic pockets on either side of -helix 3 (on PABP1). Part
of the region of Leishmania PABP1 that eIF4E4 interacts
with is the MFLE motif, which is a variant of the standard
MLLE motif, and using a mutated PBAP1(J) protein do-
main we have confirmed the importance of F525 as a key
part of the hydrophobic pocket that accommodates M140
of eIF4E4.
Our NMR analyses have also revealed that the N-
terminal extension of eIF4E4 is naturally disordered, and
that interaction with PABP1 induces at least partial folding
of this region.Unfolded-folded transitions have been shown
to be a common theme in other binding processes involving
cap-complex factors; for example as the result of interac-
tions between human eIF4E and eIF4G (38), and between
human eIF4E and 4E-binding proteins (39). There are also
many other instances in nature in which unfolded-folded
transitions are thought to be triggered by protein-protein
interactions (40). Moreover, PAM2 motifs generally occur
in naturally disordered regions (41), as is the case in Leish-
mania eIF4E4. Since there is evidence that phosphorylation
of disordered PAM2-containing protein regions can modu-
late binding to PABCdomains (42), the observation that the
N-terminal region of eIF4E4 is the target of multiple phos-
phorylation events (11) suggests that this type of modifica-
tion might regulate the molecular interactions of eIF4E4.
Previous studies of initiation complexes in yeast, mam-
malian and plant systems have revealed evidence of co-
operativity of the interactions between components in
the molecular chain mRNA5′-m7G-eIF4E-eIF4G-PABP-
poly(A)-3′mRNA (19–25). Of particular relevance here
are published data obtained with yeast and human
proteins indicating modulation of PABP-eIF4G inter-
actions by poly(A) binding to PABP (20,43). As we
have seen, the Leishmania eIF4G3–eIF4E4(cap4)-PABP1-
poly(A) biomolecular chain lacks direct binding between
eIF4G3 and PABP1, and this raised the question whether
the binding of poly(A) ribonucleotides to PABP1 might in-
stead modulate the binding affinity between PABP1 and
eIF4E4. Our results suggest that the changes in the roles
of the respective translation factors in Leishmania have cre-
ated a biomolecular chain that functions without poly(A)-
mediated modulation of protein-protein interactions. This
outcome is consistent with the observation that the PABP1
PABC domain forms a stable fold in solution that is only
minimally altered by binding of the eIF4E4 peptide.
It is also noteworthy that, although still classifiable as
of relatively high affinity, the interactions between the
Leishmania cap-binding-complex proteins reported here are
weaker than those reported previously for eukaryotic eIF4E
and eIF4G (for example in yeast the KD for this interaction
= 2.3 × 10−9 M; 44). The apparently lower stability of the
Leishmania interactions could potentially signify that the
translation initiation complexes in at least the promastig-
ote form of this organism are more dynamically assem-
bled and disassembled than in other eukaryotes, but more
work will be required to test this hypothesis. It is also of
interest that the dissociation constant value estimated us-
ing microscale thermophoresis for PABP1(J) binding to the
eIF4E4(iv) protein domain (KD = 0.22 × 10−7M) is very
similar to that observed for PABP1(J) binding to the 14mer
eIF4E4 peptide (KD = 0.33 × 10−7 M). This suggests that
the primary determinants of eIF4E4 binding are contained
in the PAM2 motif.
Finally, this quantitative study has focused on key in-
teractions and structures underpinning the unique archi-
tecture of the Leishmania eIF4G3–eIF4E4(cap4)–PABP1–
poly(A) biomolecular chain that links the 5′ and 3′ ends of
trypanosomatid mRNAs. We anticipate that future work
will build on these insights to help expand this picture by
exploring a wider network of interactions involving other
translation factors, such as the DEAD-box RNA-binding
protein eIF4A. We note that such future work could reveal
further interaction interfaces that may be worthy of consid-
eration as potential drug targets.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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